Stay updated on Cardiol Therapeutics Press Releases
Sign up to get notified when there's something new on the Cardiol Therapeutics Press Releases page.

Latest updates to the Cardiol Therapeutics Press Releases page
- ChecktodayChange DetectedThe Press Releases page now shows updated stock quotes in the header ($1.995 and $2.75), and adds entries for the US$150 million shelf prospectus filing and two upcoming investor conferences on Sept 9–10, 2026. It also removes several MAVERIC-related press releases from April 2026.SummaryDifference4%

- Check7 days agoChange DetectedDifference0.4%

- Check15 days agoChange DetectedStock price figures on the investor page were updated. The previous values of $1.86 and $2.58 were replaced with $1.94 and $2.70.SummaryDifference0.4%

- Check22 days agoChange DetectedStock tickers NASDAQ:CRDL and TSX:CRDL were added to the page header along with current share prices $2.58 and $1.86. A Subscribe button was added to the investor resources area.SummaryDifference1%

- Check29 days agoChange DetectedThe Press Releases page no longer displays the stock tickers TSX:CRDL and NASDAQ:CRDL or the prices $1.99 and $1.42, removing quick-access stock data from that section. This modifies how investors access current financial information on the page.SummaryDifference0.9%

- Check36 days agoChange DetectedUpdated stock prices to $1.42 and $1.99 and added a new press release about Cardiol Therapeutics' participation in Canaccord Genuity's 46th Annual Growth Conference; older stock prices ($1.27, $1.76) and the press release Cardiol Therapeutics Announces Year-End 2025 Update on Operations were removed.SummaryDifference1%

Stay in the know with updates to Cardiol Therapeutics Press Releases
Enter your email address, and we'll notify you when there's something new on the Cardiol Therapeutics Press Releases page.